Lead Medical Director GI Oncology Clinical Development

GlaxoSmithKline; Waltham (MA); Hybrid; USD 223,000 - 371,000; Full time

Benefits offered by this job

Annual bonus

Health and other insurance

Retirement benefits

Paid holidays

Parental and medical leave

Job summary

GlaxoSmithKline is seeking a Medical Director for Oncology Clinical Development with a GI focus. The role combines medical oversight of studies, data interpretation, and cross-functional collaboration to accelerate impactful cancer therapies.

Based in the US (Waltham, MA) with UK Stevenage options and potential relocation to Cambridge, UK, the position requires senior leadership in a matrix environment and close engagement with regulatory bodies and external experts.

Qualifications

• MD with board certification or eligibility in oncology or haematology.
• Experience in clinical trial conduct including monitoring and safety review.
• Strong knowledge of GCP, ICH guidelines, and global regulatory frameworks.

Responsibilities

• Serve as medical lead for oncology GI clinical development programmes.
• Lead medical monitoring activities and safety oversight for studies.
• Interpret safety and efficacy data to inform decision-making.
• Collaborate with cross-functional teams to integrate clinical insights.
• Contribute to regulatory documents and external scientific communications.
• Engage with investigators and KEEs to support study conduct.

Skills

MD with oncology board

Clinical trial design

Medical monitoring

Safety data interpretation

Regulatory affairs

Cross-functional leadership

Scientific communication

GCP/ICH knowledge

Education

MD or equivalent

Job description

GlaxoSmithKline is seeking a Medical Director for Oncology Clinical Development with a GI focus. The role combines medical oversight of studies, data interpretation, and cross-functional collaboration to accelerate impactful cancer therapies.

Based in the US (Waltham, MA) with UK Stevenage options and potential relocation to Cambridge, UK, the position requires senior leadership in a matrix environment and close engagement with regulatory bodies and external experts.